Hassan J Matthew, Cookson Michael S, Smith Joseph A, Chang Sam S
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765, USA.
J Urol. 2006 Jun;175(6):2054-7. doi: 10.1016/S0022-5347(06)00323-5.
We characterized initial relapse patterns in patients who underwent cystectomy for transitional cell carcinoma of the bladder at our institution.
Between June 1995 and December 2001 a total of 417 patients underwent radical cystectomy for transitional cell carcinoma. Of the 399 patients treated with orthotopic diversion or incontinent cutaneous diversion, recurrent TCC developed in 86 (21.6%). We retrospectively examined this population to determine if any perioperative variables influenced the first site of disease recurrence.
Of the 86 patients in whom metastatic disease developed after cystectomy, the mean followup was 22.1 months. Mean time to disease recurrence was 15.1 months. Recurrence was most commonly initially in the pelvis (30.2%). Other common sites of first recurrence included the viscera (26.7%), the retroperitoneum (16.3%) and the skeletal system (16.3%). The site of first recurrence did not correlate significantly with gender, age, diversion type, pathological stage, nodal status, prostatic involvement or the presence of a positive surgical margin. Lymphovascular invasion was more prevalent in the pelvic recurrence group (62%) than in the retroperitoneal (36%), visceral (22%) or skeletal metastases (29%) groups (p = 0.03).
While the pelvis is the most common site of disease recurrence following radical cystectomy, TCC of the bladder recurs in an unpredictable pattern and aggressive surveillance is indicated. Patients with local pelvic recurrence had a higher percentage of lymphovascular invasion on cystectomy than the other recurrence site groups.
我们对在我院接受膀胱移行细胞癌膀胱切除术患者的初始复发模式进行了特征分析。
1995年6月至2001年12月期间,共有417例患者因移行细胞癌接受了根治性膀胱切除术。在399例接受原位尿流改道或非可控性皮肤尿流改道治疗的患者中,86例(21.6%)出现了复发性移行细胞癌。我们对这一群体进行了回顾性研究,以确定是否有任何围手术期变量会影响疾病复发的首发部位。
在86例膀胱切除术后发生转移性疾病的患者中,平均随访时间为22.1个月。疾病复发的平均时间为15.1个月。复发最常见于盆腔(30.2%)。其他常见的首次复发部位包括内脏(26.7%)、腹膜后(16.3%)和骨骼系统(16.3%)。首次复发部位与性别、年龄、尿流改道类型、病理分期、淋巴结状态、前列腺受累情况或手术切缘阳性与否均无显著相关性。盆腔复发组的淋巴管侵犯发生率(62%)高于腹膜后转移组(36%)、内脏转移组(22%)或骨骼转移组(29%)(p = 0.03)。
虽然盆腔是根治性膀胱切除术后疾病复发最常见的部位,但膀胱移行细胞癌的复发模式难以预测,因此需要积极监测。与其他复发部位组相比,局部盆腔复发患者膀胱切除术后淋巴管侵犯的比例更高。